Davinder P. Dosanjh

Birmingham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABA.

Phase 2a randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of londamocitinib (AZD4604) two times per day for 12 weeks in adult patients with moderate-to-severe asthma uncontrolled on medium-high-dose ICS-LABA.

Journal: BMJ open respiratory research

Published: July 04, 2025

Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives.

Neutrophil dynamics in pulmonary fibrosis: pathophysiological and therapeutic perspectives.

Journal: European respiratory review : an official journal of the European Respiratory Society

Published: June 18, 2024

Practices to prevent non-ventilator hospital-acquired pneumonia: a narrative review.

Practices to prevent non-ventilator hospital-acquired pneumonia: a narrative review.

Journal: The Journal of hospital infection

Published: December 21, 2023

Clinical challenge of diagnosing non-ventilator hospital-acquired pneumonia and identifying causative pathogens: a narrative review.

Clinical challenge of diagnosing non-ventilator hospital-acquired pneumonia and identifying causative pathogens: a narrative review.

Journal: The Journal of hospital infection

Published: December 21, 2023

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.

Journal: ERJ open research

Published: July 24, 2023

PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V).

PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V).

Journal: Trials

Published: December 11, 2022

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial.

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial.

Journal: The Lancet. Respiratory medicine

Published: May 25, 2022

Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational study.

Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational study.

Journal: Clinical medicine (London, England)

Published: January 26, 2022

Coronary artery thrombus resulting in ST-elevation myocardial infarction in a patient with COVID-19.

Coronary artery thrombus resulting in ST-elevation myocardial infarction in a patient with COVID-19.

Journal: BMJ case reports

Published: August 26, 2021

Mouth care matters - A HAP prevention strategy.

Mouth care matters - A HAP prevention strategy.

Journal: The Journal of infection

Published: May 14, 2021

COVID-19 admission risk tools should include multiethnic age structures, multimorbidity and deprivation metrics for air pollution, household overcrowding, housing quality and adult skills.

COVID-19 admission risk tools should include multiethnic age structures, multimorbidity and deprivation metrics for air pollution, household overcrowding, housing quality and adult skills.

Journal: BMJ open respiratory research

Published: April 06, 2021

Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.

Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia.

Journal: Journal of clinical immunology

Published: March 31, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026